We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TMDX market cap is 4.35B. The company's latest EPS is USD -0.7650 and P/E is -173.87.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 41.55M | 52.47M | 66.43M | 81.17M | 96.85M |
| Operating Income | -2.09M | -906k | -28.34M | 2.6M | 12.42M |
| Net Income | -2.64M | -1M | -25.42M | 4.03M | 12.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 23.6M | 25.64M | 30.26M | 93.46M | 241.62M |
| Operating Income | -29.6M | -26.38M | -39.43M | -31.44M | -28.73M |
| Net Income | -33.55M | -28.75M | -44.22M | -36.23M | -25.03M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 287.09M | 690.36M | 689.23M | 706.05M | 723.83M |
| Total Liabilities | 94.46M | 545.15M | 562.77M | 568.85M | 564.36M |
| Total Equity | 192.63M | 145.21M | 126.46M | 137.2M | 159.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 105.3M | 152.03M | 134.89M | 277.15M | 706.05M |
| Total Liabilities | 50.65M | 48.14M | 67.04M | 89.77M | 568.85M |
| Total Equity | 54.65M | 103.89M | 67.85M | 187.38M | 137.2M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.66M | -14.46M | -21.33M | -13.03M | -3.44M |
| Investing | -927k | -2.31M | -152.14M | -193.95M | -44.17M |
| Financing | 3.96M | 397.97M | 399.49M | 400.42M | 3.19M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -32.29M | -30.27M | -28.86M | -45.82M | -13.03M |
| Investing | -60.5M | -41.6M | 29.27M | 54.51M | -193.95M |
| Financing | 92.72M | 75.55M | 1.39M | 167.93M | 400.42M |
| Market Cap | 4.35B |
| Price to Earnings Ratio | -173.87 |
| Price to Sales Ratio | 18.01 |
| Price to Cash Ratio | 11.02 |
| Price to Book Ratio | 31.72 |
| Dividend Yield | - |
| Shares Outstanding | 32.72M |
| Average Volume (1 week) | 800.64k |
| Average Volume (1 Month) | 752.75k |
| 52 Week Change | 78.62% |
| 52 Week High | 144.225 |
| 52 Week Low | 36.4201 |
| Spread (Intraday) | 1.15 (0.86%) |
| Company Name | TransMedics Group Inc |
| Address |
200 minuteman road andover, massachusetts 01810 |
| Website | https://www.transmedics.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
